Skip to content
10-Q

Quarterly Report

Sunshine Biopharma Inc. SBFM SBFMW

0001683168-25-008328

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 4.91M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.93M sh
Shares Diluted Q3 2025 · Sep 30, 2024 218.63K sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $0
Stock Repurchased Q3 2025 · Sep 30, 2024 $3.14M
Capex Q3 2025 · Sep 30, 2025 $175.53K
Capex Q3 2025 · Sep 30, 2024 $1.55M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.72M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$9.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 $24.2M
Stockholders Equity Q3 2025 · Jun 30, 2025 $25.68M
Stockholders Equity Q3 2025 · Dec 31, 2024 $23.5M
Stockholders Equity Q3 2025 · Sep 30, 2024 $25.04M
Stockholders Equity Q3 2025 · Jun 30, 2024 $23.49M
Stockholders Equity Q3 2025 · Dec 31, 2023 $21.21M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.65M
Current Liabilities Q3 2025 · Dec 31, 2024 $6.31M
Total Liabilities Q3 2025 · Sep 30, 2025 $7.29M
Total Liabilities Q3 2025 · Dec 31, 2024 $7.06M
Current Assets Q3 2025 · Sep 30, 2025 $27.97M
Current Assets Q3 2025 · Dec 31, 2024 $25.97M
Total Assets Q3 2025 · Sep 30, 2025 $31.49M
Total Assets Q3 2025 · Dec 31, 2024 $30.56M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.98
Eps Diluted Q3 2025 · Sep 30, 2024 −$13.61
Eps Basic Q3 2025 · Sep 30, 2025 −$0.19
Eps Basic Q3 2025 · Sep 30, 2025 −$0.98
Eps Basic Q3 2025 · Sep 30, 2024 −$0.94
Eps Basic Q3 2025 · Sep 30, 2024 −$13.61
Sga Expense Q3 2025 · Sep 30, 2025 $4.16M
Sga Expense Q3 2025 · Sep 30, 2025 $13.66M
Sga Expense Q3 2025 · Sep 30, 2024 $3.97M
Sga Expense Q3 2025 · Sep 30, 2024 $11.35M
Rd Expense Q3 2025 · Sep 30, 2025 $119.3K
Rd Expense Q3 2025 · Sep 30, 2025 $530.81K
Rd Expense Q3 2025 · Sep 30, 2024 $126.36K
Rd Expense Q3 2025 · Sep 30, 2024 $784.63K
Net Income Q3 2025 · Sep 30, 2025 −$883.82K
Net Income Q3 2025 · Sep 30, 2025 −$3.83M
Net Income Q3 2025 · Sep 30, 2024 −$1.2M
Net Income Q3 2025 · Sep 30, 2024 −$2.98M
Operating Income Q3 2025 · Sep 30, 2025 −$1.09M
Operating Income Q3 2025 · Sep 30, 2025 −$4.44M
Operating Income Q3 2025 · Sep 30, 2024 −$1.11M
Operating Income Q3 2025 · Sep 30, 2024 −$3.77M
Gross Profit Q3 2025 · Sep 30, 2025 $3.07M
Gross Profit Q3 2025 · Sep 30, 2025 $9.23M
Gross Profit Q3 2025 · Sep 30, 2024 $2.87M
Gross Profit Q3 2025 · Sep 30, 2024 $7.58M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $6.34M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $18.5M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $5.57M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $17.7M
Revenue Q3 2025 · Sep 30, 2025 $9.42M
Revenue Q3 2025 · Sep 30, 2025 $27.73M
Revenue Q3 2025 · Sep 30, 2024 $8.44M
Revenue Q3 2025 · Sep 30, 2024 $25.28M